COLOGNESI, MARTINA

COLOGNESI, MARTINA  

Dipartimento di Scienze del Farmaco - DSF  

Mostra records
Risultati 1 - 7 di 7 (tempo di esecuzione: 0.012 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
A novel HER2-targeted liposomal formulation for reducing the risk of liposome-induced hepatotoxicity 2020 Sara De MartinSamantha SarcognatoDaniela GabbiaElena CanatoMartina ColognesiNora CazzagonMaria GuidoGianfranco Pasut. JOURNAL OF HEPATOLOGY - -
A Nutraceutical Formulation Containing Brown Algae Reduces Hepatic Lipid Accumulation by Modulating Lipid Metabolism and Inflammation in Experimental Models of NAFLD and NASH 2022 Gabbia, DanielaRoverso, MarcoZanotto, IlariaColognesi, MartinaSayaf, KatiaSarcognato, SamanthaArcidiacono, DilettaZaramella, AliceFerri, NicolaGuido, MariaRusso, Francesco PaoloBogialli, SaraCarrara, MariaDe Martin, Sara + MARINE DRUGS - -
Depression and cognitive impairment-Extrahepatic manifestations of NAFLD and NASH 2020 Colognesi M.Gabbia D.De Martin S. BIOMEDICINES - -
Targeting glutamatergic and serotoninergic signaling to treat neurodegenerative and metabolic disorders. 2024 COLOGNESI, MARTINA - - -
The Extra Virgin Olive Oil Polyphenol Oleocanthal Exerts Antifibrotic Effects in the Liver 2021 Gabbia D.Sarcognato S.Cannella L.Colognesi M.Scaffidi M.Macchia M.Carrara M.Russo F. P.Guido M.De Martin S. + FRONTIERS IN NUTRITION - -
The phenolic compounds tyrosol and hydroxytyrosol counteract liver fibrogenesis via the transcriptional modulation of NADPH oxidases and oxidative stress-related miRNAs 2023 Gabbia, DanielaSarcognato, SamanthaZanotto, IlariaSayaf, KatiaColognesi, MartinaCarrara, MariaCazzagon, NoraRusso, Francesco PaoloDe Martin, Sara + BIOMÉDECINE & PHARMACOTHÉRAPIE - -
Tyrosol attenuates NASH features by reprogramming the hepatic immune milieu 2024 Gabbia, DanielaSayaf, KatiaZanotto, IlariaColognesi, MartinaFrion-Herrera, YahimaCarrara, MariaRusso, Francesco PaoloDe Martin, Sara EUROPEAN JOURNAL OF PHARMACOLOGY - -